
Ae1 Ae3 Antibody Bafilomycin A1 Bile Acid Assay Bioassay Blog Choline Acetyltransferase Antibody Deoxycholic Acid Sodium Salt ELISA kit Epz 6438 Hdac Activity Assay immune Isotype Ldn 193189 Medium Mothers Against Decapentaplegic Mouse Albumin Elisa Pamabrom 100Mg Pepstatin A peptide Phospho 4Ebp1 Polyclonal Purification Ru 58841 Soft Agar Trypsin Activity Assay Tubastatin A Uric Acid Assay Valproic Acid Sodium Salt Western Blot
Tandem Ubiquitin Binding Entities (TUBEs) as Tools to Explore Ubiquitin-Proteasome System and PROTAC Drug Discovery
Lieven
- 0
The ubiquitin proteasome system (UPS) is a fancy pathway that entails a number of enzymes and culminates within the formation of a polyubiquitin chain on a goal protein. As its significance is turning into extra evident in drug discovery, there’s a renewed curiosity in understanding the function that polyubiquitin chains play.
This has been a problem, largely because of the lack of experimental instruments for detecting the polyubiquitinated types of a protein of curiosity (POI). Tandem Ubiquitin Binding Entities (TUBEs) are engineered protein domains that bind particularly to polyubiquitin chains. These polyubiquitin affinity matrices are extremely delicate as they bind to polyubiquitin chains within the nanomolar vary.
They exist in two kinds: pan-selective TUBEs and chain-selective TUBEs. The flexibility of TUBEs to be conjugated to totally different entities is really what makes them distinctive. TUBEs are utilized in all kinds of experiments comparable to in protein pulldowns to complement for polyubiquitinated proteins. They’re an alternative choice to ubiquitin antibodies in Western blots.
Additional, TUBEs are used as seize reagents for immobilizing polyubiquitinated proteins on a microtiter plate. Using TUBEs as parts of in vitro and cell-based assays presents the distinctive function of confirming and assessing the polyubiquitination of a POI in response to inhibitors, activators, or PROTAC® molecules. Subsequently, TUBEs not solely play a giant function in finding out the usbut even have an enormous potential for rushing up the drug discovery course of.
A Novel Luminescence-Primarily based Excessive-Throughput Method for Mobile Decision of Protein Ubiquitination Utilizing Tandem Ubiquitin Binding Entities (TUBEs).
Protein turnover is extremely regulated by the posttranslational strategy of ubiquitination. Deregulation of the ubiquitin proteasome system (UPS) has been implicated in most cancers and neurodegenerative illnesses, and modulating this method has confirmed to be a viable strategy for therapeutic intervention. The event of novel applied sciences that allow high-throughput research of substrate protein ubiquitination is essential for UPS drug discovery.
Typical approaches for finding out ubiquitination both have excessive protein necessities or depend on exogenous or modified ubiquitin moieties, thus limiting their utility. As a way to circumvent these points, we developed a high-throughput live-cell assay that mixes the NanoBiT luminescence-based expertise with tandem ubiquitin binding entities (TUBEs) to resolve substrate ubiquitination.
To reveal the effectiveness and utility of this assay, we studied compound-induced ubiquitination of the G to S Part Transition 1 (GSPT1) protein. Utilizing this assay, we characterised compounds with various ranges of GSPT1 ubiquitination exercise.
This methodology gives a live-cell-based strategy for assaying substrate ubiquitination that may be tailored to review the kinetics of ubiquitin switch onto a substrate protein of curiosity. As well as, our outcomes present that this strategy is transportable for finding out the ubiquitination of goal proteins with various features.
New insights into host-parasite ubiquitin proteome dynamics in P. falciparum contaminated purple blood cells utilizing a TUBEs-MS strategy.
Malaria, attributable to Plasmodium falciparum (P. falciparum), ranks as some of the baleful infectious illnesses worldwide. New antimalarial therapies are wanted to face present or rising drug resistant strains. Protein degradation seems to play a big function through the asexual intraerythrocytic developmental cycle (IDC) of P. falciparum.
Inhibition of the ubiquitin proteasome system (UPS), a serious intracellular proteolytic pathway, successfully reduces an infection and parasite replication. P. falciparum and erythrocyte UPS coexist throughout IDC however the nature of their relationship is essentially unknown. We used an strategy primarily based on Tandem Ubiquitin-Binding Entities (TUBEs) and 1D gel electrophoresis adopted by mass spectrometry to determine main parts of the TUBEs-associated ubiquitin proteome of each host and parasite throughout ring, trophozoite and schizont levels.
Ring-exported protein (REX1), a P. falciparum protein situated in Maurer’s clefts and vital for parasite nutrient import, was discovered to succeed in a most stage of ubiquitylation in trophozoites stage. The Homo sapiens (H. sapiens) TUBEs related ubiquitin proteome decreased through the an infection, whereas the equal P. falciparum TUBEs-associated ubiquitin proteome counterpart elevated. Main mobile processes comparable to DNA restore, replication, stress response, vesicular transport and catabolic occasions look like regulated by ubiquitylation alongside the IDC P. falciparum an infection.
The Hectd1 ubiquitin ligase is required for growth of the top mesenchyme and neural tube closure.
Closure of the cranial neural tube is determined by regular growth of the top mesenchyme. Homozygous-mutant embryos for the ENU-induced open thoughts (opm) mutation exhibit exencephaly related to defects in head mesenchyme growth and dorsal-lateral hinge level formation. The top mesenchyme in opm mutant embryos is denser than in wildtype embryos and shows an irregular mobile group.
Since cells that originate from each the cephalic paraxial mesoderm and the neural crest populate the top mesenchyme, we explored the origin of the irregular head mesenchyme. opm mutant embryos present apparently regular growth of neural crest-derived constructions. Moreover, the irregular head mesenchyme in opm mutant embryos will not be derived from the neural crest, however as an alternative expresses molecular markers of cephalic mesoderm.
We additionally report the identification of the opm mutation within the ubiquitously expressed Hectd1 E3 ubiquitin ligase. Two totally different Hectd1 alleles trigger incompletely penetrant neural tube defects in heterozygous animals, indicating that Hectd1 perform is required at a important threshold for neural tube closure. This low penetrance of neural tube defects in embryos heterozygous for Hectd1 mutations means that Hectd1 needs to be thought-about as candidate susceptibility gene in human neural tube defects.

A quick stream tube examine of fuel section H/D trade of multiply protonated ubiquitin.
An electrospray ionization (ESI)/fast-flow method has been utilized to the examine of fuel section hydrogen/deuterium (H/D) trade kinetics. Multiply charged ubiquitin ions [ubiquitin + nH](n)(+), in cost states n = 7-13, have been reacted with ND(3). The conduct of ND(3) as trade reagent is totally different from that of the beforehand studied reagents, D(2)O and CH(3)OD.
Opposite to these, the utmost variety of exchanged hydrogen atoms and the general trade fee have been noticed to extend with rising cost state of the ubiquitin ions. The outcomes are reagent-dependent as a result of the trade mechanisms are totally different for the totally different reagents. This remark is in settlement with a current conclusion by Beauchamp and colleagues that opposite to the idea usually expressed in earlier research, H/D trade kinetics could indirectly replicate ion constructions.
The outcomes for all three reagents are, nonetheless, according to observations of earlier ion mobility experiments that with rising cost state the conformers change from extra compact, partially folded constructions to elongated practically linear ones. H/D trade of (ubiquitin + 13H)(13+) with ND(3) results in two separated ion populations reflecting the potential existence of two conformers with totally different trade charges. The ions (ubiquitin + 8H)(8+) and (ubiquitin + 11H)(11+) signify {a partially} folded construction and an unfolded construction, respectively, and have been studied in better element.
The relative abundances of ions have been measured in steps of 0.5 m/z (mass-to-charge ratio), as a perform of the ND(3) stream fee. The experimental outcomes have been simulated by laptop fitted curves primarily based on a not too long ago developed algorithm. The algorithm permits the extraction of units of grouped fee constants. Eight fee fixed teams have been deduced for every of the 2 ions.
ubiquitin (Ubiquitin) Antibody (ALP) |
|||
abx444810-100ug | Abbexa | 100 ug | EUR 477.6 |
ubiquitin (Ubiquitin) Antibody (APC) |
|||
abx444814-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (HRP) |
|||
abx444826-100ug | Abbexa | 100 ug | EUR 477.6 |
ubiquitin (Ubiquitin) Antibody (RPE) |
|||
abx444838-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ALP) |
|||
abx442291-200ug | Abbexa | 200 ug | EUR 744 |
ubiquitin (Ubiquitin) Antibody (ALP) |
|||
abx442300-200ug | Abbexa | 200 ug | EUR 744 |
ubiquitin (Ubiquitin) Antibody (HRP) |
|||
abx443413-200ug | Abbexa | 200 ug | EUR 727.2 |
ubiquitin (Ubiquitin) Antibody (HRP) |
|||
abx443422-200ug | Abbexa | 200 ug | EUR 727.2 |
ubiquitin (Ubiquitin) Antibody (RPE) |
|||
abx444256-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (RPE) |
|||
abx444265-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (APC) |
|||
abx442572-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (APC) |
|||
abx442581-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ALP) |
|||
abx447954-200ul | Abbexa | 200 ul | EUR 744 |
ubiquitin (Ubiquitin) Antibody (APC) |
|||
abx447955-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (HRP) |
|||
abx447958-200ul | Abbexa | 200 ul | EUR 727.2 |
ubiquitin (Ubiquitin) Antibody (RPE) |
|||
abx447961-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (FITC) |
|||
abx444822-100ug | Abbexa | 100 ug | EUR 477.6 |
ubiquitin (Ubiquitin) Antibody (FITC) |
|||
abx443133-200ug | Abbexa | 200 ug | EUR 744 |
ubiquitin (Ubiquitin) Antibody (FITC) |
|||
abx443142-200ug | Abbexa | 200 ug | EUR 744 |
ubiquitin (Ubiquitin) Antibody (FITC) |
|||
abx447957-200ul | Abbexa | 200 ul | EUR 744 |
ubiquitin (Ubiquitin) Antibody (PerCP) |
|||
abx444834-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (PerCP) |
|||
abx443975-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (PerCP) |
|||
abx443984-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (PerCP) |
|||
abx447960-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (Biotin) |
|||
abx444818-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (Biotin) |
|||
abx442853-200ug | Abbexa | 200 ug | EUR 744 |
ubiquitin (Ubiquitin) Antibody (Biotin) |
|||
abx442862-200ug | Abbexa | 200 ug | EUR 744 |
ubiquitin (Ubiquitin) Antibody (Biotin) |
|||
abx447956-200ul | Abbexa | 200 ul | EUR 744 |
ubiquitin (Ubiquitin) Antibody (ATTO 390) |
|||
abx444778-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 488) |
|||
abx444782-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 565) |
|||
abx444786-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 594) |
|||
abx444790-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 633) |
|||
abx444794-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 655) |
|||
abx444798-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 680) |
|||
abx444802-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 700) |
|||
abx444806-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (ATTO 390) |
|||
abx440043-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 390) |
|||
abx440052-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 488) |
|||
abx440324-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 488) |
|||
abx440333-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 565) |
|||
abx440605-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 565) |
|||
abx440614-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 594) |
|||
abx440886-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 594) |
|||
abx440895-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 633) |
|||
abx441167-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 633) |
|||
abx441176-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 655) |
|||
abx441448-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 655) |
|||
abx441457-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 680) |
|||
abx441729-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 680) |
|||
abx441738-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 700) |
|||
abx442010-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 700) |
|||
abx442019-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 390) |
|||
abx447946-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 488) |
|||
abx447947-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 565) |
|||
abx447948-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 594) |
|||
abx447949-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 633) |
|||
abx447950-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 655) |
|||
abx447951-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 680) |
|||
abx447952-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (ATTO 700) |
|||
abx447953-200ul | Abbexa | 200 ul | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (Streptavidin) |
|||
abx444537-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (Streptavidin) |
|||
abx444546-200ug | Abbexa | 200 ug | EUR 760.8 |
ubiquitin (Ubiquitin) Antibody (Streptavidin) |
|||
abx444842-100ug | Abbexa | 100 ug | EUR 493.2 |
ubiquitin (Ubiquitin) Antibody (Streptavidin) |
|||
abx447962-200ul | Abbexa | 200 ul | EUR 760.8 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (AP) |
|||
MBS6442391-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (AP) |
|||
MBS6442391-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (PE) |
|||
MBS6442401-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (PE) |
|||
MBS6442401-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (APC) |
|||
MBS6442392-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (APC) |
|||
MBS6442392-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (HRP) |
|||
MBS6442395-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (HRP) |
|||
MBS6442395-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (FITC) |
|||
MBS6442394-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (FITC) |
|||
MBS6442394-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
ubiquitin (Ubiquitin) Antibody (PE/ATTO 594) |
|||
abx444830-100ug | Abbexa | 100 ug | EUR 510 |
ubiquitin (Ubiquitin) Antibody (PE/ATTO 594) |
|||
abx443694-200ug | Abbexa | 200 ug | EUR 777.6 |
ubiquitin (Ubiquitin) Antibody (PE/ATTO 594) |
|||
abx443703-200ug | Abbexa | 200 ug | EUR 777.6 |
ubiquitin (Ubiquitin) Antibody (PE/ATTO 594) |
|||
abx447959-200ul | Abbexa | 200 ul | EUR 777.6 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (Biotin) |
|||
MBS6442393-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (Biotin) |
|||
MBS6442393-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (AP) |
|||
MBS6504474-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (AP) |
|||
MBS6504474-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (PE) |
|||
MBS6504484-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (PE) |
|||
MBS6504484-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (APC) |
|||
MBS6504475-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (APC) |
|||
MBS6504475-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Recombinant Solanum tuberosum Ubiquitin-40S ribosomal protein S27a (UBI3) |
|||
MBS1254505-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1000 |
Recombinant Solanum tuberosum Ubiquitin-40S ribosomal protein S27a (UBI3) |
|||
MBS1254505-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 565 |
Recombinant Solanum tuberosum Ubiquitin-40S ribosomal protein S27a (UBI3) |
|||
MBS1254505-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 755 |
Recombinant Solanum tuberosum Ubiquitin-40S ribosomal protein S27a (UBI3) |
|||
MBS1254505-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 675 |
Recombinant Solanum tuberosum Ubiquitin-40S ribosomal protein S27a (UBI3) |
|||
MBS1254505-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 880 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (FITC) |
|||
MBS6504477-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (FITC) |
|||
MBS6504477-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (Biotin) |
|||
MBS6504476-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (Biotin) |
|||
MBS6504476-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 405) |
|||
MBS6442396-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 405) |
|||
MBS6442396-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 490) |
|||
MBS6442397-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 490) |
|||
MBS6442397-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 550) |
|||
MBS6442398-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 550) |
|||
MBS6442398-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 650) |
|||
MBS6442399-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 650) |
|||
MBS6442399-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 750) |
|||
MBS6442400-01mL | MyBiosource | 0.1mL | EUR 950 |
Ubiquitin C (UBC, HMG20, Ubiquitin) (MaxLight 750) |
|||
MBS6442400-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
Ubiquitin |
|||
GWB-DF6295 | GenWay Biotech | 0.01 mg | Ask for price |
UBIQUITIN |
|||
GWB-693DA3 | GenWay Biotech | 0.25 mg | Ask for price |
Ubiquitin |
|||
E8ER31212 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
Ubiquitin |
|||
E8ET1609-21 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
Ubiquitin |
|||
MBS6508421-05mg | MyBiosource | 0.5mg | EUR 980 |
Ubiquitin |
|||
MBS6508421-5x05mg | MyBiosource | 5x0.5mg | EUR 4250 |
Ubiquitin |
|||
MBS6508422-01mL | MyBiosource | 0.1mL | EUR 765 |
Ubiquitin |
|||
MBS6508422-5x01mL | MyBiosource | 5x0.1mL | EUR 3300 |
Ubiquitin |
|||
MBS6508424-01mL | MyBiosource | 0.1mL | EUR 660 |
Ubiquitin |
|||
MBS6508424-5x01mL | MyBiosource | 5x0.1mL | EUR 2810 |
Ubiquitin |
|||
MBS6508425-01mL | MyBiosource | 0.1mL | EUR 660 |
Ubiquitin |
|||
MBS6508425-5x01mL | MyBiosource | 5x0.1mL | EUR 2810 |
Ubiquitin |
|||
MO18001 | Neuromics | 100 ul | EUR 454.5 |
Ubiquitin |
|||
MO22152 | Neuromics | 100 ul | EUR 292.5 |
Ubiquitin |
|||
MBS8533864-01mL | MyBiosource | 0.1mL | EUR 345 |
Ubiquitin |
|||
MBS8533864-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Ubiquitin |
|||
MBS8533864-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Ubiquitin |
|||
MBS8533864-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Ubiquitin |
|||
MBS8533864-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Ubiquitin |
|||
MBS8533588-01mL | MyBiosource | 0.1mL | EUR 345 |
Ubiquitin |
|||
MBS8533588-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Ubiquitin |
|||
MBS8533588-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Ubiquitin |
|||
MBS8533588-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Ubiquitin |
|||
MBS8533588-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Ubiquitin |
|||
PR27083 | Neuromics | 50 ug | EUR 97.2 |
Ubiquitin |
|||
PR27083-B | Neuromics | each | EUR 184.5 |
Ubiquitin |
|||
pro-314 | ProSpec Tany | 10µg | EUR 60 |
Description: Recombinant Human Ubiquitin |
Ubiquitin |
|||
RA22154 | Neuromics | each | EUR 296.1 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (AP) |
|||
MBS6360882-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (AP) |
|||
MBS6360882-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (PE) |
|||
MBS6360892-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (PE) |
|||
MBS6360892-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 405) |
|||
MBS6504479-01mL | MyBiosource | 0.1mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 405) |
|||
MBS6504479-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 490) |
|||
MBS6504480-01mL | MyBiosource | 0.1mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 490) |
|||
MBS6504480-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 550) |
|||
MBS6504481-01mL | MyBiosource | 0.1mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 550) |
|||
MBS6504481-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 650) |
|||
MBS6504482-01mL | MyBiosource | 0.1mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 650) |
|||
MBS6504482-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 750) |
|||
MBS6504483-01mL | MyBiosource | 0.1mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (MaxLight 750) |
|||
MBS6504483-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (APC) |
|||
MBS6360883-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (APC) |
|||
MBS6360883-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (FITC) |
|||
MBS6360885-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (FITC) |
|||
MBS6360885-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (Biotin) |
|||
MBS6360884-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, CT (UBC, Polyubiquitin-C, Ubiquitin) (Biotin) |
|||
MBS6360884-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (Azide free) (HRP) |
|||
MBS6504478-02mL | MyBiosource | 0.2mL | EUR 980 |
Ubiquitin, NT (Ubiquitin B, UBB, hCG_1998947) (Azide free) (HRP) |
|||
MBS6504478-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Ubiquitin Hydrolase L1, CT (PGP9.5, Ubiquitin CT Hydrolase L1, UCH, UCHL1, Ubiquitin thiolesterase, PARK5) |
|||
MBS6007377-1mg | MyBiosource | 1(mg | EUR 910 |
Ubiquitin Hydrolase L1, CT (PGP9.5, Ubiquitin CT Hydrolase L1, UCH, UCHL1, Ubiquitin thiolesterase, PARK5) |
|||
MBS6007377-5x1mg | MyBiosource | 5x1mg | EUR 3935 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (AP) |
|||
MBS6504650-01mL | MyBiosource | 0.1mL | EUR 890 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (AP) |
|||
MBS6504650-5x01mL | MyBiosource | 5x0.1mL | EUR 3845 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (APC) |
|||
MBS6504651-01mL | MyBiosource | 0.1mL | EUR 890 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (APC) |
|||
MBS6504651-5x01mL | MyBiosource | 5x0.1mL | EUR 3845 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (FITC) |
|||
MBS6504653-01mL | MyBiosource | 0.1mL | EUR 890 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (FITC) |
|||
MBS6504653-5x01mL | MyBiosource | 5x0.1mL | EUR 3845 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (HRP) |
|||
MBS6504654-01mL | MyBiosource | 0.1mL | EUR 890 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (HRP) |
|||
MBS6504654-5x01mL | MyBiosource | 5x0.1mL | EUR 3845 |
Ubiquitin Conjugating Enzyme (E2N, UBE2N, Ubiquitin-conjugating Enzyme E2 N, Ubiquitin-protein Ligase N, Ubiquitin carrier protein N, Ubc13, Bendless-like ubiquitin-conjugating enzyme, BLU) (PE) |
|||
MBS6504660-01mL | MyBiosource | 0.1mL | EUR 890 |
×
These fee constants correspond to 32 and 44 H/D exchanges for the 8+ and 11+ charged ions, respectively. The outcomes point out increased particular person charges for many of the exchanged atoms within the 11+ ion in comparison with the 8+ ion.
Tags: 10x tbs amcyan b actin primers buy plasmids cmv gfp common sequencing primers dcas9 p300 flag tag nucleotide sequence gibson assembly kit gibson assembly neb gst sequence lambda dna mcherry sequence midi prep kit myc tag dna sequence neb xho i nfkb reporter plasmid p3xflag cmv 14 pbluescriptr pbr322 plasmid pcdna3 vector pcold vector pegfp vector pet 28 novagen pet 28a pet23b pet24a pet28a novagen pet28a vector map pet42a pgex pgex 6p 1 sequence phrl pires vector plasmid map generator plasmid purchase plko shrna pmirglo pmx plasmid pqe vector protein gel staining psumo puc18 plasmid restriction enzyme buffer sumo protease sumo tag sequence topo vector topo vector sequence tre3g xhoi